Management of Major Bleeding Events in Patients Treated With Rivaroxaban Versus Warfarin: Results From the ROCKET AF Trial

被引：0

作者：

Piccini, Jonathan P. ^{[1
]}

Garg, Jyotsna ^{[2
]}

Patel, Manesh R. ^{[1
]}

Lokhnygina, Yuliya ^{[3
]}

Goodman, Shaun G. ^{[4
,5
]}

Becker, Richard C. ^{[1
]}

Berkowitz, Scott D. ^{[6
]}

Breithardt, Gunter ^{[7
]}

Hacke, Werner ^{[8
]}

Halperin, Jonathan L. ^{[9
]}

Hankey, Graeme I. ^{[10
,11
]}

Nessel, Christopher C. ^{[12
]}

Mahaffey, Kenneth W. ^{[1
]}

Singer, Daniel E. ^{[13
,14
]}

Califf, Robert M. ^{[15
]}

Fox, Keith A. ^{[16
,17
]}

机构：

[1] Duke Clin Rsch Inst, Dept Med, Div Cardiol, Durham, NC USA

[2] Duke Clin Rsch Inst, Stat Grp, Durham, NC USA

[3] Duke Clin Rsch Inst, Dept Biostat & Bioinformat, Durham, NC USA

[4] Univ Toronto, St Michaels Hosp, Canadian Heart Rsch Cntr, Toronto, ON, Canada

[5] Terrence Donnelly Heart Cntr, Toronto, ON, Canada

[6] Bayer HealthCare Pharmaceut, Global Therapeut Rsch, Cardiovasc Pharmacol, Montville, NJ USA

[7] Hosp Univ Munster, Dept Cardiol & Angiol, Munster, Germany

[8] Heidelberg Univ, Dept Neurol, Heidelberg, Germany

[9] Mt Sinai, Icahn Sch Med, Mt Sinai Med Cntr, Cardiovasc Inst, New York, NY USA

[10] Univ Western Australia, Sch Med & Pharmacol, Dept Neurol, Perth, WA 6009, Australia

[11] Royal Perth Hosp, Stroke Unit, Perth, WA 6001, Australia

[12] Janssen Rsch & Dev, Clin Rsch, Raritan, NJ USA

[13] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA

[14] Harvard Univ, Sch Med, Boston, MA USA

[15] Duke Translat Med Inst, Dept Med, Div Cardiol, Durham, NC USA

[16] Univ Edinburgh, Cntr Cardiovasc Sci, Edinburgh, Midlothian, Scotland

[17] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland

来源：

CIRCULATION | 2013年 / 128卷 / 22期

关键词：

Atrial fibrillation; Stroke; Risk factors;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

15879

引用

页数：2

共 50 条

[31] Rivaroxaban versus warfarin in Japanese patients with non-valvular atrial fibrillation in relation to hypertension: a subgroup analysis of the J-ROCKET AF trial
Matsumoto, Masayasu
Hori, Masatsugu
Tanahashi, Norio
Momomura, Shin-ichi
Uchiyama, Shinichiro
Goto, Shinya
Izumi, Tohru
Koretsune, Yukihiro
Kajikawa, Mariko
Kato, Masaharu
Ueda, Hitoshi
Iekushi, Kazuma
Yamanaka, Satoshi
Tajiri, Masahiro
HYPERTENSION RESEARCH, 2014, 37 (05) : 457 - 462
[32] Recurrent venous thromboembolism and major bleeding in patients treated with rivaroxaban or warfarin for venous thromboembolism in routine practice
Coleman, C.
Bunz, T. J.
EUROPEAN HEART JOURNAL, 2017, 38 : 1037 - 1037
[33] Assessment of Bleeding Risk and Cerebrovascular Events in Bipolar Disorder Patients With Atrial Fibrillation on Warfarin Versus Rivaroxaban
Khalid, Sidra
Thapa, Bicky
Wajahat, Rana
Covut, Fahrettin
Clark, Bernadette A.
Daw, Hamed
AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (05) : E641 - E644
[34] Are major bleeding events from falls more likely in patients on warfarin?
Garvin, R
Howard, E
JOURNAL OF FAMILY PRACTICE, 2006, 55 (02): : 157 - 158
[35] On-treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF
Fordyce, Christopher B.
Hellkamp, Anne S.
Lokhnygina, Yuliya
Lindner, Samuel M.
Piccini, Jonathan P.
Becker, Richard C.
Berkowitz, Scott D.
Breithardt, Guenter
Fox, Keith A.
Halperin, Jonathan L.
Hankey, Graeme J.
Mahaffey, Kenneth W.
Nesse, Christopher C.
Singer, Daniel E.
Patel, Manesh R.
CIRCULATION, 2015, 132
[36] On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin Insights From ROCKET AF
Fordyce, Christopher B.
Hellkamp, Anne S.
Lokhnygina, Yuliya
Lindner, Samuel M.
Piccini, Jonathan P.
Becker, Richard C.
Berkowitz, Scott D.
Breithardt, Guenter
Fox, Keith A. A.
Mahaffey, Kenneth W.
Nessel, Christopher C.
Singer, Daniel E.
Patel, Manesh R.
CIRCULATION, 2016, 134 (01) : 37 - +
[37] Predictive factors for bleeding during treatment with rivaroxaban and warfarin in Japanese patients with atrial fibrillation - Subgroup analysis of J-ROCKET AF
Hori, Masatsugu
Matsumoto, Masayasu
Tanahashi, Norio
Momomura, Shin-ichi
Uchiyama, Shinichiro
Goto, Shinya
Izumi, Tohru
Koretsune, Yukihiro
Kajikawa, Mariko
Kato, Masaharu
Cavaliere, Mary
Iekushi, Kazuma
Yamanaka, Satoshi
JOURNAL OF CARDIOLOGY, 2016, 68 (5-6) : 523 - 528
[38] Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial
Held, Claes
Hylek, Elaine M.
Alexander, John H.
Hanna, Michael
Lopes, Renato D.
Wojdyla, Daniel M.
Thomas, Laine
Al-Khalidi, Hussein
Alings, Marco
Xavier, Dennis
Ansell, Jack
Goto, Shinya
Ruzyllo, Witold
Rosenqvist, Marten
Verheugt, Freek W. A.
Zhu, Jun
Granger, Christopher B.
Wallentin, Lars
EUROPEAN HEART JOURNAL, 2015, 36 (20) : 1264 - 1272
[39] Blood Pressure Control and Stroke or Bleeding Risk in Patients with Atrial Fibrillation: Results from the ROCKET AF Trial
Vemulapalli, Sreekanth
Hellkamp, Anne S.
Jones, W. Schuyler
Piccini, Jonathan P.
Mahaffey, Kenneth W.
Becker, Richard C.
Hankey, Graeme J.
Berkowitz, Scott D.
Breithardt, Guenter
Singer, Daniel E.
Fox, Keith A.
Califf, Robert M.
Patel, Manesh R.
CIRCULATION, 2014, 130
[40] Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation in Relation to the CHADS2 Score: A Subgroup Analysis of the J-ROCKET AF Trial
Hori, Masatsugu
Matsumoto, Masayasu
Tanahashi, Norio
Momomura, Shin-ichi
Uchiyama, Shinichiro
Goto, Shinya
Izumi, Tohru
Koretsune, Yukihiro
Kajikawa, Mariko
Kato, Masaharu
Ueda, Hitoshi
Iekushi, Kazuma
Yamanaka, Satoshi
Tajiri, Masahiro
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (02): : 379 - 383

← 1 2 3 4 5 →